{"id":"NCT00462709","sponsor":"Shire","briefTitle":"Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks","officialTitle":"LEVP2006-4 CHANGE 3 Trial (C1-Inhibitor in Hereditary Angioedema Nanofiltration Generation Evaluating Efficacy): Open-Label Use of C1INH-nf (Human) for the Prophylactic Treatment to Prevent HAE Attacks and as Treatment in Acute HAE Attacks","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-06-27","primaryCompletion":"2009-03-31","completion":"2009-03-31","firstPosted":"2007-04-19","resultsPosted":"2010-05-03","lastUpdate":"2021-06-08"},"enrollment":146,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Hereditary Angioedema"],"interventions":[{"type":"BIOLOGICAL","name":"C1 esterase inhibitor [human] (C1INH-nf)","otherNames":[]}],"arms":[{"label":"Open-label C1INH-nf","type":"EXPERIMENTAL"}],"summary":"The study objective was to evaluate the safety and efficacy of prophylactic use of C1INH-nf for the prevention of acute HAE attacks.","primaryOutcome":{"measure":"Frequency of All HAE Attacks","timeFrame":"Duration of the study","effectByArm":[{"arm":"Open-label C1INH-nf","deltaMin":3,"sd":null}],"pValues":[]},"eligibility":{"minAge":"1 Year","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":48,"countries":["United States"]},"refs":{"pmids":["36326435","23484892","23312695","20818886"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":146},"commonTop":["Headache","Rash","Nausea","Phlebitis"]}}